APO RESEARCH · REPORT
Glycomics & Glycobiology
Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
Product & engineering
Understand the product.
Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.
Selected research
Market Structure
Global Glycomics & Glycobiology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.
Global Glycomics/Glycobiology key players include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, etc. Global top four manufacturers hold a share over 15%.
Read the full market overview
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Instruments is the largest segment, with a share about 33%. And in terms of application, the largest application is Drug Discovery & Development, followed by Diagnostics, etc.
Report Includes
This report provides an overview of the global Glycomics & Glycobiology market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Glycomics & Glycobiology and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Glycomics & Glycobiology revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Glycomics & Glycobiology market size, projected growth trends, production technologies, key applications, and end-use industries.
Glycomics & Glycobiology Segment by Company
ThermoFisher Scientific
Danaher
Shimadzu Corporation
ProZyme
Takara Bio, Inc.
Agilent Technologies
Bruker
Promega
Waters Corporation
R&D Systems
New England Biolabs
Merck KGaA
Glycomics & Glycobiology Segment by Type
Instruments
Enzymes
Reagents
Kits
Glycomics & Glycobiology Segment by Application
Drug Discovery & Development
Diagnostics
Others
Glycomics & Glycobiology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycomics & Glycobiology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glycomics & Glycobiology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycomics & Glycobiology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Glycomics & Glycobiology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glycomics & Glycobiology industry.
Chapter 3: Detailed analysis of Glycomics & Glycobiology companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Glycomics & Glycobiologyrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Instruments
- Enzymes
- Reagents
- Kits
Applications
- Drug Discovery & Development
- Diagnostics
- Others
Companies covered
- ThermoFisher Scientific
- Danaher
- Shimadzu Corporation
- ProZyme
- Takara Bio, Inc.
- Agilent Technologies
- Bruker
- Promega
- Waters Corporation
- R&D Systems
- New England Biolabs
- Merck KGaA
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Glycomics & Glycobiology Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Instruments
- 1.2.3 Enzymes
- 1.2.4 Reagents
- 1.2.5 Kits
- 1.3 Market Analysis by Application
- 1.3.1 Global Glycomics & Glycobiology Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Drug Discovery & Development
- 1.3.3 Diagnostics
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Glycomics & Glycobiology Growth Trends by Region
- 1.5.1 Global Glycomics & Glycobiology Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Glycomics & Glycobiology Market Size by Region (2021-2026)
- 1.5.3 Glycomics & Glycobiology Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Glycomics & Glycobiology Market Dynamics
- 2.1 Glycomics & Glycobiology Industry Trends
- 2.2 Glycomics & Glycobiology Industry Drivers
- 2.3 Glycomics & Glycobiology Industry Opportunities and Challenges
- 2.4 Glycomics & Glycobiology Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Glycomics & Glycobiology Revenue by Company (2021-2026)
- 3.2 Global Glycomics & Glycobiology Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Glycomics & Glycobiology Key Company Head office and Area Served
- 3.4 Global Glycomics & Glycobiology Company, Product Type & Application
- 3.5 Global Glycomics & Glycobiology Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Glycomics & Glycobiology Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Glycomics & Glycobiology Players Market Share by Revenue in 2025
- 3.6.3 2025 Glycomics & Glycobiology Tier 1, Tier 2, and Tier 3
4 Glycomics & Glycobiology Market by Type
- 4.1 Global Glycomics & Glycobiology Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Glycomics & Glycobiology Market Size by Type (2021-2032)
- 4.3 Global Glycomics & Glycobiology Market Size Share by Type (2021-2032)
5 Glycomics & Glycobiology Market by Application
- 5.1 Global Glycomics & Glycobiology Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Glycomics & Glycobiology Market Size by Application (2021-2032)
- 5.3 Global Glycomics & Glycobiology Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 ThermoFisher Scientific
- 6.1.1 ThermoFisher Scientific Company Information
- 6.1.2 ThermoFisher Scientific Business Overview
- 6.1.3 ThermoFisher Scientific Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 ThermoFisher Scientific Glycomics & Glycobiology Product Portfolio
- 6.1.5 ThermoFisher Scientific Recent Developments
- 6.2 Danaher
- 6.2.1 Danaher Company Information
- 6.2.2 Danaher Business Overview
- 6.2.3 Danaher Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Danaher Glycomics & Glycobiology Product Portfolio
- 6.2.5 Danaher Recent Developments
- 6.3 Shimadzu Corporation
- 6.3.1 Shimadzu Corporation Company Information
- 6.3.2 Shimadzu Corporation Business Overview
- 6.3.3 Shimadzu Corporation Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Shimadzu Corporation Glycomics & Glycobiology Product Portfolio
- 6.3.5 Shimadzu Corporation Recent Developments
- 6.4 ProZyme
- 6.4.1 ProZyme Company Information
- 6.4.2 ProZyme Business Overview
- 6.4.3 ProZyme Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 ProZyme Glycomics & Glycobiology Product Portfolio
- 6.4.5 ProZyme Recent Developments
- 6.5 Takara Bio, Inc.
- 6.5.1 Takara Bio, Inc. Company Information
- 6.5.2 Takara Bio, Inc. Business Overview
- 6.5.3 Takara Bio, Inc. Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Takara Bio, Inc. Glycomics & Glycobiology Product Portfolio
- 6.5.5 Takara Bio, Inc. Recent Developments
- 6.6 Agilent Technologies
- 6.6.1 Agilent Technologies Company Information
- 6.6.2 Agilent Technologies Business Overview
- 6.6.3 Agilent Technologies Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Agilent Technologies Glycomics & Glycobiology Product Portfolio
- 6.6.5 Agilent Technologies Recent Developments
- 6.7 Bruker
- 6.7.1 Bruker Company Information
- 6.7.2 Bruker Business Overview
- 6.7.3 Bruker Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Bruker Glycomics & Glycobiology Product Portfolio
- 6.7.5 Bruker Recent Developments
- 6.8 Promega
- 6.8.1 Promega Company Information
- 6.8.2 Promega Business Overview
- 6.8.3 Promega Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Promega Glycomics & Glycobiology Product Portfolio
- 6.8.5 Promega Recent Developments
- 6.9 Waters Corporation
- 6.9.1 Waters Corporation Company Information
- 6.9.2 Waters Corporation Business Overview
- 6.9.3 Waters Corporation Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Waters Corporation Glycomics & Glycobiology Product Portfolio
- 6.9.5 Waters Corporation Recent Developments
- 6.10 R&D Systems
- 6.10.1 R&D Systems Company Information
- 6.10.2 R&D Systems Business Overview
- 6.10.3 R&D Systems Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 R&D Systems Glycomics & Glycobiology Product Portfolio
- 6.10.5 R&D Systems Recent Developments
- 6.11 New England Biolabs
- 6.11.1 New England Biolabs Company Information
- 6.11.2 New England Biolabs Business Overview
- 6.11.3 New England Biolabs Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 New England Biolabs Glycomics & Glycobiology Product Portfolio
- 6.11.5 New England Biolabs Recent Developments
- 6.12 Merck KGaA
- 6.12.1 Merck KGaA Company Information
- 6.12.2 Merck KGaA Business Overview
- 6.12.3 Merck KGaA Glycomics & Glycobiology Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Merck KGaA Glycomics & Glycobiology Product Portfolio
- 6.12.5 Merck KGaA Recent Developments
7 North America
- 7.1 North America Glycomics & Glycobiology Market Size (2021-2032)
- 7.2 North America Glycomics & Glycobiology Market Size by Type
- 7.2.1 North America Glycomics & Glycobiology Market Size by Type (2021-2026)
- 7.2.2 North America Glycomics & Glycobiology Market Size by Type (2027-2032)
- 7.2.3 North America Glycomics & Glycobiology Market Share by Type (2021-2032)
- 7.3 North America Glycomics & Glycobiology Market Size by Application
- 7.3.1 North America Glycomics & Glycobiology Market Size by Application (2021-2026)
- 7.3.2 North America Glycomics & Glycobiology Market Size by Application (2027-2032)
- 7.3.3 North America Glycomics & Glycobiology Market Share by Application (2021-2032)
- 7.4 North America Glycomics & Glycobiology Market Size by Country
- 7.4.1 North America Glycomics & Glycobiology Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Glycomics & Glycobiology Market Size by Country (2021-2026)
- 7.4.3 North America Glycomics & Glycobiology Market Size by Country (2027-2032)
- 7.4.4 North America Glycomics & Glycobiology Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Glycomics & Glycobiology Market Size (2021-2032)
- 8.2 Europe Glycomics & Glycobiology Market Size by Type
- 8.2.1 Europe Glycomics & Glycobiology Market Size by Type (2021-2026)
- 8.2.2 Europe Glycomics & Glycobiology Market Size by Type (2027-2032)
- 8.2.3 Europe Glycomics & Glycobiology Market Share by Type (2021-2032)
- 8.3 Europe Glycomics & Glycobiology Market Size by Application
- 8.3.1 Europe Glycomics & Glycobiology Market Size by Application (2021-2026)
- 8.3.2 Europe Glycomics & Glycobiology Market Size by Application (2027-2032)
- 8.3.3 Europe Glycomics & Glycobiology Market Share by Application (2021-2032)
- 8.4 Europe Glycomics & Glycobiology Market Size by Country
- 8.4.1 Europe Glycomics & Glycobiology Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Glycomics & Glycobiology Market Size by Country (2021-2026)
- 8.4.3 Europe Glycomics & Glycobiology Market Size by Country (2027-2032)
- 8.4.4 Europe Glycomics & Glycobiology Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Glycomics & Glycobiology Market Size (2021-2032)
- 9.2 China Glycomics & Glycobiology Market Size by Type
- 9.2.1 China Glycomics & Glycobiology Market Size by Type (2021-2026)
- 9.2.2 China Glycomics & Glycobiology Market Size by Type (2027-2032)
- 9.2.3 China Glycomics & Glycobiology Market Share by Type (2021-2032)
- 9.3 China Glycomics & Glycobiology Market Size by Application
- 9.3.1 China Glycomics & Glycobiology Market Size by Application (2021-2026)
- 9.3.2 China Glycomics & Glycobiology Market Size by Application (2027-2032)
- 9.3.3 China Glycomics & Glycobiology Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Glycomics & Glycobiology Market Size (2021-2032)
- 10.2 Asia Glycomics & Glycobiology Market Size by Type
- 10.2.1 Asia Glycomics & Glycobiology Market Size by Type (2021-2026)
- 10.2.2 Asia Glycomics & Glycobiology Market Size by Type (2027-2032)
- 10.2.3 Asia Glycomics & Glycobiology Market Share by Type (2021-2032)
- 10.3 Asia Glycomics & Glycobiology Market Size by Application
- 10.3.1 Asia Glycomics & Glycobiology Market Size by Application (2021-2026)
- 10.3.2 Asia Glycomics & Glycobiology Market Size by Application (2027-2032)
- 10.3.3 Asia Glycomics & Glycobiology Market Share by Application (2021-2032)
- 10.4 Asia Glycomics & Glycobiology Market Size by Country
- 10.4.1 Asia Glycomics & Glycobiology Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Glycomics & Glycobiology Market Size by Country (2021-2026)
- 10.4.3 Asia Glycomics & Glycobiology Market Size by Country (2027-2032)
- 10.4.4 Asia Glycomics & Glycobiology Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Glycomics & Glycobiology Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Glycomics & Glycobiology Market Size by Type
- 11.2.1 South America, Middle East & Africa Glycomics & Glycobiology Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Glycomics & Glycobiology Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Glycomics & Glycobiology Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Glycomics & Glycobiology Market Size by Application
- 11.3.1 South America, Middle East & Africa Glycomics & Glycobiology Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Glycomics & Glycobiology Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Glycomics & Glycobiology Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Glycomics & Glycobiology Market Size by Country
- 11.4.1 South America, Middle East & Africa Glycomics & Glycobiology Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Glycomics & Glycobiology Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Glycomics & Glycobiology Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Glycomics & Glycobiology Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst